The pathologies of AIDs have been extensively investigated to favor mechanism of action (MOA) of anti-CD38 mAb, featured with potency to reduce autoantibody secretion via CD38-positive (CD38+) cells depletion. The gene discussed is CD38; the disease is AIDS.